Calluna Pharma

Calluna Pharma is the operator of a clinical-stage company that intends to develop new therapies by harnessing the transformative potential of the human immune system. The company focuses on the precise targeting of upstream innate immune amplifiers, disrupting a range of disease-related downstream signaling pathways while maintaining good safety. This enables new therapeutic candidates to address unmet clinical needs across a spectrum of diseases driven by acute or chronic inflammation and non-lytic tissue fibrosis.